Skip to content

Anxiety: all studies

Page 262 of 769: studies 2,611 to 2,620 of 7,689, newest first. Back to the anxiety overview

Research

Effects of a Mindfulness-Based Intervention on Self-Compassion and Psychological Health Among Young Adults With a History of Childhood Maltreatment

Frontiers in Psychology October 23, 2019 Diane Joss, Alaptagin Khan, Sara W. Lazar et al. 63 citations

Individuals who were maltreated during childhood are faced with increased risks for developing various psychological symptoms that are particularly resistant to traditional treatments. This pilot study investigated the effects of a mindfulness based behavioral intervention for young adults with childhood maltreatment history. This study looked at self-report psychological questionnaires from 20...

Mindfulness meditation, time judgment and time experience: Importance of the time scale considered (seconds or minutes)

PLoS One October 18, 2019 Sylvie Droit-Volet, Magali Chaulet, Frédéric Dutheil et al. 22 citations

This manuscript presents two studies on the effect of mindfulness meditation on duration judgment and its relationship to the subjective experience of time when the interval durations are on the second or the minute time scale. After the first 15 minutes of a 30-min meditation or control exercise, meditation-trained participants judged interval durations of 15 to 50 s or 2 to 6 min, during...

Attachment-based compassion therapy and adapted mindfulness-based stress reduction for the treatment of depressive, anxious and adjustment disorders in mental health settings: a randomised controlled clinical trial protocol.

BMJ Open October 8, 2019 Jesus Montero-Marin, Carlos Collado-Navarro, Mayte Navarro‐gil et al.

Introduction: Depressive, anxiety and adjustment disorders are highly prevalent among mental health outpatients. The lack of funding for mental health problems produces inefficient results and a high burden of disease. New cost-effective group interventions aimed at treating these symptoms might be an appropriate solution to reduce the healthcare burden in mental health units. Mindfulness-based...

Mindfulness, acceptance, and emotion regulation: Perspectives from Monitor and Acceptance Theory (MAT)

October 5, 2019 Emily K. Lindsay, J. David Creswell 11 citations

Experiential acceptance—an orientation of receptivity and noninterference with present-moment experiences—is described as central to mindfulness interventions, yet little experimental work has tested acceptance as a mechanism for mindfulness intervention effects. Guided by Monitor and Acceptance Theory (MAT), this review situates acceptance as an emotion regulation mechanism and reviews...

DOI: 10.31231/osf.io/xtrgb (opens in new tab) Mindfulness Anxiety Psychological intervention Mechanism biology +7

Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness

Journal of Psychoactive Drugs September 30, 2019 Maha N. Mian, Brianna R. Altman, Mitch Earleywine 47 citations

Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on changes in mindfulness. This study investigated whether both mindfulness and...

Acute effects of lysergic acid diethylamide (LSD) on resting brain function

Swiss Medical Weekly September 30, 2019 Felix Mller, Stefan Borgwardt 10 citations

Lysergic acid diethylamide (LSD) is a potent hallucinogenic substance that was extensively investigated by psychiatrists during the 1950s and 1960s. Researchers were interested in the unique effects induced by this substance, some of which resemble symptoms seen in schizophrenia. Moreover, during that period LSD was studied and used for the treatment of several mental disorders such as...

The psychedelic renaissance: the next trip for psychiatry?

Irish Journal of Psychological Medicine September 23, 2019 John R. Kelly, Annie Baker, Mona Babiker et al. 22 citations

The psychedelic research renaissance is gaining traction. Preliminary clinical studies of the hallucinogenic fungi, psilocybin, with psychological support, have indicated improvements in mood, anxiety and quality of life. A seminal, open-label study demonstrated marked reductions in depression symptoms in participants with treatment-resistant depression (TRD). The associated neurobiological...

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers

Frontiers in Psychiatry September 13, 2019 Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder et al. 78 citations

Background: There is a growing interest in the use of psychedelic substances for health related purposes, including symptom relief for disorders like anxiety, depression, and pain. Although the focus of recent clinical trials has been on high doses of these substances, anecdotal evidence suggests that low (micro) doses are also effective, and may be more suitable for certain conditions....

DOI: 10.3389/fpsyt.2019.00672 (opens in new tab) Anxiety Mental health Depression economics Clinical psychology

Psilocybin for depression: Considerations for clinical trial design

Journal of Psychedelic Studies September 1, 2019 Kelley C. O’donnell, Sarah E. Mennenga, Michael P. Bogenschutz 15 citations

Background and aims Given the enormous global burden of depressive illness, there is an urgent need to develop novel and more effective treatments for major depressive disorder (MDD). Recent findings have suggested that psychedelic drugs may have a role in the treatment of depressive symptoms, and a number of groups are in the process of developing protocols to study this question...

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

Psychopharmacology September 1, 2019 Michael C Mithoefer, Allison A. Feduccia, Lisa Jerome et al. 364 citations Retracted

Posttraumatic stress disorder is a prevalent mental health condition with substantial impact on daily functioning that lacks sufficient treatment options. Here we evaluate six phase 2 trials in a pooled analysis to determine the study design for phase 3 trials of MDMA-assisted psychotherapy for PTSD. Six randomized, double-blind, controlled clinical trials at five study sites were conducted...

DOI: 10.1007/s00213-019-05249-5 (opens in new tab) Full text (opens in new tab) MDMA-Assisted Psychotherapy Posttraumatic stress disorder MDMA Alongside Therapy Active MDMA +7